Palisades Hudson Asset Management’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $284K | Hold |
1,047
| – | – | 0.11% | 81 |
|
|
2025
Q4 | $346K | Hold |
1,047
| – | – | 0.13% | 71 |
|
|
2025
Q3 | $361K | Sell |
1,047
-31
| -3% | -$9.38K | 0.13% | 73 |
|
|
2025
Q2 | $337K | Hold |
1,078
| – | – | 0.13% | 78 |
|
|
2025
Q1 | $565K | Hold |
1,078
| – | – | 0.26% | 48 |
|
|
2024
Q4 | $546K | Hold |
1,078
| – | – | 0.23% | 53 |
|
|
2024
Q3 | $630K | Hold |
1,078
| – | – | 0.27% | 47 |
|
|
2024
Q2 | $549K | Hold |
1,078
| – | – | 0.25% | 50 |
|
|
2024
Q1 | $533K | Hold |
1,078
| – | – | 0.24% | 51 |
|
|
2023
Q4 | $567K | Hold |
1,078
| – | – | 0.28% | 49 |
|
|
2023
Q3 | $544K | Hold |
1,078
| – | – | 0.3% | 44 |
|
|
2023
Q2 | $518K | Hold |
1,078
| – | – | 0.27% | 51 |
|
|
2023
Q1 | $510K | Sell |
1,078
-13
| -1% | -$6.27K | 0.27% | 49 |
|
|
2022
Q4 | $578K | Buy |
1,091
+3
| +0.3% | +$1.59K | 0.32% | 42 |
|
|
2022
Q3 | $550K | Sell |
1,088
-50
| -4% | -$26.3K | 0.33% | 37 |
|
|
2022
Q2 | $585K | Buy |
1,138
+60
| +6% | +$30.1K | 0.33% | 42 |
|
|
2022
Q1 | $550K | Hold |
1,078
| – | – | 0.26% | 53 |
|
|
2021
Q4 | $542K | Buy |
1,078
+21
| +2% | +$9.51K | 0.23% | 55 |
|
|
2021
Q3 | $413K | Hold |
1,057
| – | – | 0.19% | 66 |
|
|
2021
Q2 | $423K | Hold |
1,057
| – | – | 0.19% | 63 |
|
|
2021
Q1 | $393K | Sell |
1,057
-293
| -22% | -$102K | 0.19% | 63 |
|
|
2020
Q4 | $473K | Hold |
1,350
| – | – | 0.24% | 50 |
|
|
2020
Q3 | $421K | Hold |
1,350
| – | – | 0.27% | 52 |
|
|
2020
Q2 | $398K | Hold |
1,350
| – | – | 0.27% | 48 |
|
|
2020
Q1 | $337K | Hold |
1,350
| – | – | 0.29% | 50 |
|
|
2019
Q4 | $397K | Hold |
1,350
| – | – | 0.25% | 52 |
|
|
2019
Q3 | $293K | Hold |
1,350
| – | – | 0.2% | 67 |
|
|
2019
Q2 | $329K | Hold |
1,350
| – | – | 0.23% | 62 |
|
|
2019
Q1 | $334K | Sell |
1,350
-590
| -30% | -$150K | 0.22% | 60 |
|
|
2018
Q4 | $483K | Hold |
1,940
| – | – | 0.28% | 42 |
|
|
2018
Q3 | $516K | Hold |
1,940
| – | – | 0.27% | 45 |
|
|
2018
Q2 | $476K | Buy |
1,940
+28
| +1% | +$6.72K | 0.26% | 42 |
|
|
2018
Q1 | $409K | Hold |
1,912
| – | – | 0.22% | 57 |
|
|
2017
Q4 | $422K | Hold |
1,912
| – | – | 0.23% | 55 |
|
|
2017
Q3 | $374K | Hold |
1,912
| – | – | 0.21% | 62 |
|
|
2017
Q2 | $355K | Hold |
1,912
| – | – | 0.21% | 63 |
|
|
2017
Q1 | $314K | Hold |
1,912
| – | – | 0.2% | 66 |
|
|
2016
Q4 | $306K | Hold |
1,912
| – | – | 0.19% | 63 |
|
|
2016
Q3 | $268K | Hold |
1,912
| – | – | 0.2% | 75 |
|
|
2016
Q2 | $270K | Hold |
1,912
| – | – | 0.22% | 71 |
|
|
2016
Q1 | $246K | Hold |
1,912
| – | – | 0.19% | 79 |
|
|
2015
Q4 | $225K | Hold |
1,912
| – | – | 0.19% | 83 |
|
|
2015
Q3 | $222K | Hold |
1,912
| – | – | 0.2% | 78 |
|
|
2015
Q2 | $233K | Hold |
1,912
| – | – | 0.2% | 78 |
|
|
2015
Q1 | $226K | Buy |
+1,912
| New | +$212K | 0.18% | 79 |
|
Other funds holding UNH
VCM
VPM
Palisades Hudson Asset Management's UNH Position: Q1 2026 in Review
Palisades Hudson Asset Management held its UnitedHealth (UNH) position steady in Q1 2026 at 1,047 shares worth $284K. The position accounts for 0.11% of the portfolio, ranked #81.
Palisades Hudson Asset Management first reported a position in UNH in Q1 2015 and has held it in 45 quarters since. The position peaked at $630K in Q3 2024. 3,025 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Palisades Hudson Asset Management held 1,047 shares of UnitedHealth worth $284K as of Q1 2026.
- Palisades Hudson Asset Management left its UnitedHealth share count unchanged in Q1 2026.
- UnitedHealth made up 0.11% of Palisades Hudson Asset Management's portfolio in Q1 2026, its #81 holding.
- Palisades Hudson Asset Management first reported a position in UnitedHealth in Q1 2015 and has held it in 45 quarters since.
- Palisades Hudson Asset Management's UnitedHealth position peaked at $630K in Q3 2024.
- 3,025 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Palisades Hudson Asset Management's 13F filing for Q1 2026, filed 8 May 2026.